SCHEMBL7035490

SCHEMBL7035490

O=C(Nc1ccc(-c2ccco2)cc1C(=O)O)c1ccc(Cl)cc1Cl.[LiH]

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 6/20 0.78
▸ PPARA Q07869 4/20 0.78
▸ SERPINE1 P05121 4/20 0.51
▸ TP53 P04637 1/20 0.48
▸ WDR5 P61964 1/20 0.48
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ HDAC2 Q92769 1/20 0.46
▸ AKR1C4 P17516 1/20 0.46
▸ AKR1C3 P42330 1/20 0.46
▸ AKR1C2 P52895 1/20 0.46
▸ AKR1C1 Q04828 1/20 0.46
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7041821 0.99 PPARG (0.80) PPARGPPARASERPINE1TP53WDR5
Lithium Ion SCHEMBL7035485 0.88 PPARG (1.00) PPARGPPARATP53WDR5CYP1A2
SCHEMBL7040714 0.87 PPARG (0.76) PPARGPPARATP53WDR5MEN1
SCHEMBL7038130 0.82 SERPINE1 (0.70) PPARGPPARASERPINE1TP53MEN1
SCHEMBL7040866 0.81 PPARG (0.67) PPARGPPARASERPINE1TP53AKR1C4
SCHEMBL1307242 0.80 PPARG (0.81) PPARGPPARASERPINE1TP53AKR1C4
SCHEMBL7040843 0.80 PPARG (0.69) PPARGPPARASERPINE1TP53AKR1C4
SCHEMBL7038137 0.80 PPARG (0.68) PPARGPPARASERPINE1TP53AKR1C4
SCHEMBL7037662 0.80 PPARG (0.56) PPARGPPARASERPINE1TP53HDAC2
SCHEMBL7038105 0.78 PPARG (0.62) PPARGPPARASERPINE1TP53AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073862-A1 Compounds BIOVITRUM AB (SE) 2003-04-17 — — US disclosed
WO-2003004458-A1 NEW COMPOUNDS BIOVITRUM AB (SE) 2003-01-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073862-A1 Compounds PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885SERPINE1 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback